Repetitive Transcranial Magnetic Stimulation for Working Memory Deficits in Schizophrenia: A Systematic Review of Randomized Controlled Trials
DOI: https://doi.org/10.2147/ndt.s450303
IF: 2.989
2024-03-22
Neuropsychiatric Disease and Treatment
Abstract:Li Li, 1, 2 Chaomeng Liu, 1, 2 Weigang Pan, 1, 2 Wen Wang, 1, 2 Wenqing Jin, 1, 2 Yanping Ren, 1, 2 Xin Ma 1, 2 1 The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, People's Republic of China Correspondence: Yanping Ren; Xin Ma, the National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, NO. 5 Ankang Hutong, Xicheng District, Beijing, 100088, People's Republic of China, Email ; Working memory (WM) deficits are a significant component of neurocognitive impairment in individuals with schizophrenia (SCZ). Two previous meta-analyses, conducted on randomized controlled trials (RCTs), examined the effectiveness of repetitive transcranial magnetic stimulation (rTMS) in addressing WM deficits in individuals diagnosed with SCZ. However, the conclusions drawn from these analyses were inconsistent. Additionally, the commonly used random effects (RE) models might underestimate statistical errors, attributing a significant portion of perceived heterogeneity between studies to variations in study quality. Therefore, this review utilized both RE and quality effects (QE) models to assess relevant RCTs comparing TMS with sham intervention in terms of clinical outcomes. A comprehensive literature search was conducted using PubMed and Scopus databases, resulting in the inclusion of 13 studies for data synthesis. Overall, regardless of whether the RE or QE model was used, eligible RCTs suggested that the TMS and sham groups exhibited comparable therapeutic effects after treatment. The current state of research regarding the use of rTMS as a treatment for WM deficits in patients with SCZ remains in its preliminary phase. Furthermore, concerning the mechanism of action, the activation of brain regions focused on the dorsolateral prefrontal cortex and alterations in gamma oscillations may hold significant relevance in the therapeutic application of rTMS for addressing WM impairments. Finally, we believe that the application of closed-loop neuromodulation may contribute to the optimization of rTMS for WM impairment in patients with SCZ. Keywords: working memory, schizophrenia, randomized controlled trials, repetitive transcranial magnetic stimulation, review Schizophrenia (SCZ), a profoundly debilitating psychiatric disorder, impacts ~21 million individuals worldwide. 1 This condition manifests with a diverse range of symptoms, including delusions, hallucinations, disorganized speech, abnormal psychomotor behavior, and negative symptoms. 2 Consequently, those diagnosed with SCZ face an elevated risk of premature mortality, contributing significantly to global disability. 3,4 Cognitive impairments are widely recognized as the primary cause of functional deficits in individuals with SCZ. 5,6 Consistent research findings indicate substantial deficits in working memory (WM) among individuals with SCZ, highlighting impairments in WM as a prevalent characteristic of the illness. 7 Studies have further established a correlation between WM and functional outcomes, suggesting that WM deficits can serve as predictive indicators for functional outcomes. 8,9 Therefore, addressing WM deficits should be prioritized as a key objective in treatment interventions aimed at enhancing functional outcomes for patients with SCZ. WM is a crucial cognitive function that involves the temporary processing and storage of information, serving as a working platform for various advanced cognitive functions such as language, learning, understanding, problem-solving, and executive functions. 10 Numerous studies have identified deficits in WM, including verbal and visual-spatial WM, among individuals with SCZ. 11 Various tasks and scales, including the n-back tool and subtests like the spatial span test and alphanumeric span test within the MATRICS Consensus Cognitive Battery (MCCB), are employed to evaluate the amelioration of WM deficits. 12 Despite the recognized importance of WM and its deficits in SCZ, current pharmacological interventions do not demonstrate efficacy in enhancing WM impairment in this population. Consequently, it is imperative to explore novel techniques and methodologies for addressing the cognitive deficit symptoms associated with SCZ, particularly those related to WM. Repetitive transcranial magnetic stimulation (rTMS), a frequently employed exper -Abstract Truncated-
psychiatry,clinical neurology